Comment évaluer le risque oncologique d'un patient souffrant de dermatomyosite [Can we predict the risk of malignancy associated with dermatomyositis?]


Autoria(s): Gainon J.; Bart P.A.; Waeber G.
Data(s)

2003

Resumo

Dermatomyositis (DM) and polymyositis (PM) are idiopathic inflammatory muscle diseases which remain a therapeutic challenge. The association between DM and malignancy is relatively well established while this relationship is weaker with PM. The clinical management and research for an occult malignancy as well as the follow-up of patients with DM or PM is a matter of debate. Herein we report a case of DM who, despite an extensive clinical, radiological and biological work-up developed an occult ovarian cancer 12 months after the initial diagnosis. This case report was used as support to review the actual expert recommendations for the search of an occult malignancy in presence of DM or PM.

Identificador

http://serval.unil.ch/?id=serval:BIB_0FF609A29505

isbn:1661-8157

pmid:14587367

Idioma(s)

fr

Fonte

Praxis, vol. 92, no. 41, pp. 1734-9

Palavras-Chave #Adenocarcinoma; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporins; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Ovarian Neoplasms; Polymyositis; Prednisone; Risk Factors; Time Factors
Tipo

info:eu-repo/semantics/article

article